Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

NICE declines to recommend Astellas' Xospata in rlapsed/refractory FLT3+ acute myeloid leukaemia
The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the recommendation of Astellas’ Xospata (...
No NICE recommendation for AstraZeneca's Tagrisso in EGFR+ lung cancer
AstraZeneca’s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug watchdog NICE in the...
EU apoproval for Roche's Polivy combo in relapsed/refractory B-cell lymphoma
The European Commission has awarded conditional marketing approval to Roche’s Polivy for the treatment of relapsed or refractory diffuse large B-...
Jazz Pharma's Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea
Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve...
>> More Sales and Marketing News Stories

Features

Collaborating to realise the potential of precision medicine

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the industry...

>> More Features

Appointments

Ipsen appoints new Exec VP and Chief Medical Officer

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches